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http://dx.doi.org/10.1016/j.ccr.2014.06.004Chauhan et al. suggest that vascular
collapse and hypoperfusion in pancreatic
ductal adenocarcinoma (PDA) are caused
by solid stress (SS) (Chauhan et al., 2014)
instead of the elevated interstitial fluid
pressure (IFP) associated with high extra-
vascular concentrations of hyaluronan
(Provenzano et al., 2012). We appreciate
their attention to our work and the oppor-
tunity to clarify underlying mechanisms.
Chauhan et al. make four important
claims, to which we respond.
First, that IFP equilibrates with and
cannot exceed microvascular pressure
(MVP). Starling’s principles of fluid flux
(see the Supplemental Discussion avail-
able online) reveal that IFP need not
be limited by MVP, and Jain and col-
leagues have themselves shown this
with wick-in-needle (WN) measurements
of 94 mmHg in cervical cancer and
79 mmHg in head-and-neck cancer (Jain
et al., 2007). Further, when Chauhan
et al. state that our interpretation ‘‘is not
consistent with the physiology of fluid
homeostasis,’’ the precise physiology in
question is important. Their theoretical
framework of tumor physiology derives
largely from studying engrafted and
ex vivo tumor models that typically have
hypervascular tumor beds with increased
permeability and hydraulic conductivity
(‘‘leaky’’ vessels). However, autochtho-
nous PDAs are hypovascular and have
blood vessels that are functionally and
structurally similar to those of healthy
pancreata (Jacobetz et al., 2013).
Finally, the postmortem persistence of
elevated IFP in autochthonous PDA
(Provenzano et al., 2012) and our16 Cancer Cell 26, July 14, 2014 ª2014 Elsevdissection of IFP into that due to free
and nonmobile fluid phases (see below)
demonstrate that this claim is not al-
ways true.
Second, that IFP cannot compress
blood vessels. Two, among several,
pathophysiological conditions refute this
assertion. Compartment syndrome re-
sults from fluid accumulation in a virtual
space defined by muscle and fascia;
fluid pressures can rise to >100 mmHg
after trauma, compressing vessels and
compromising limb viability. Acute
angle-closure glaucoma results from
accumulation of free fluid in the posterior
chamber of the eye, compressing the
optic nerve and blood flow. Thus, fluid
pressures can compress blood vessels
in certain contexts.
Third, that SS is elevated in PDA and
vessel decompression by PEGPH20 oc-
curs solely by reducing SS. To estimate
SS, Jain and colleagues measured the
‘‘gape’’ in partially transected tumor ex-
plants, which suggested that B16-F10
melanoma spheroids had higher SS than
PDA; by this criterion, PDA appeared to
have among the lowest SS of all cancers
studied (Stylianopoulos et al., 2012).
Lacking the requisite data on bulk and
shear moduli, which can vary widely
across tissue and tumor types, that study
provides no calculation for SS in PDA.
Most recently, they applied this approach
to KPC PDA cell explants and calculated
SS at 11.5–18 mmHg (Y. Boucher, 2013,
GI Cancer Etiology, Prevention, and Early
Detection Seminar Series, Seattle, WA),
which is less than 20% of the pressures
wemeasured in autochthonous PDA (Pro-ier Inc.venzano et al., 2012) and suggests that
SS is not themajor determinant of intersti-
tial pressure in this setting.
Fourth, that the discrepancy between
our respective results stems from our
measurement of SS as IFP. Jain and
colleagues conclude that the piezoelec-
tric pressure catheter (PC) must be
measuring SS. From the third response
above, it follows that if the PC measures
SS, then their combined mathematical
and explant approach to SS must be
flawed; conversely, if their method is
valid, then the PC does not measure SS.
Furthermore, contrary to their claim,
normal tissues often show positive IFP
by a variety of methods (Figures S1A
and S1B).
So, why the discrepancy between
instruments? It has long been appre-
ciated that IFP involves two components:
freely mobile and relatively immobile
fluid phases (Brace, 1981). The majority
of interstitial fluid is immobile (historically
also called gel fluid, although not all
the oncotically active molecules form
a gel). The highly charged nature of hya-
luronan contributes extensively to both
hydrostatic and oncotic fluid pressures
in the interstitium, but hydrated hya-
luronan is not a gel: it partitions into the
soluble fraction after tissue homogeni-
zation and demonstrates Newtonian
viscosities over a wide range of con-
centrations and shear rates (see the
Supplemental Discussion). Part of this
debate may therefore lie in the semantics
of ‘‘fluids’’ and ‘‘solids’’ when con-
sidering solutions with viscoelastic
properties.
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takes into account both fluid phases is
IFPtotal =pv sðpv piÞ+Pimmobile+Pimmobile:
The first two terms describe classical
Starling forces with reflection coefficient
s; Pimm and Pimm represent the hydro-
static and oncotic components of fluid
pressure, respectively, in the immobile-
fluid phase (see the Supplemental Discus-
sion). Historical methods for measuring
IFP—including micropipette, needle,
WN, and perforated capsule—can mea-
sure pressure only in the free-fluid phase
(reviewed in Brace, 1981). In contrast,
the PC measures fluid pressures associ-
ated with both phases.
To test our hypotheses, we measured
IFP in several different transplanted
tumors. As expected, the PC typically
measured higher basal IFP than the WN,
and the difference correlated with hyalur-
onan content (Figures S1C and S1D).
These measurements converged after
systemic PEGPH20 (Figure S1E), which
degrades hyaluronan and liberates the
large reservoir of immobilized fluid, leav-
ing essentially only free fluid.
The hypothesized difficulties of WN to
accurately and rapidly measure fluid
pressures were tested in solutions con-
taining only water and increasing con-
centrations of hyaluronan (Figure S1F).
Even in pure solutions of hyaluronan,the WN does not fully capture fluid
pressure.
Moreover, we reconfigured the PC as a
piezoelectric catheter-in-needle (PC-N) to
shield the probe from any potential SS
(Figure S1G). IFP with PC and PC-N
were identical (32 ± 8 mmHg versus 31 ±
10 mmHg, respectively), and both were
higher than that with WN (25 ± 8 mmHg).
If the PC was primarily or even partially
measuring SS, then the PC-N would reg-
ister considerably lower values.
Finally, we have never suggested that
PDA vessels are ‘‘nonpermeable to mac-
romolecules,’’ as stated by Chauhan
et al., and have instead demonstrated
the opposite (Provenzano et al., 2012).
They present as evidence for leaky ves-
sels that PEGPH20 ‘‘permeates across
PDA vessels’’ and that nab-paclitaxel
improves survival. In fact, leaky vessels
are not required for these molecules to
reach the interstitium: PEGPH20 readily
depletes interstitial hyaluronan from
normal organs (Jacobetz et al., 2013; Pro-
venzano et al., 2012), and macromolec-
ular chemotherapies can produce toxic-
ities to normal tissues with intact vessels.
Brace notes that many investigators
equated the free-fluid component of inter-
stitial pressure with IFP because that was
all that was measurable with classical
techniques (Figure S1H); this seemed
reasonable at the time because the pri-
mary interest then was in edema (Brace,Cancer C1981). We are no longer limited to, nor
solely interested in, measuring the free-
fluid component of IFP. Indeed, the immo-
bilized-fluid phase is the major barrier
to drug delivery in PDA; we can nowquan-
tify it, identify its source, and offer rem-
edies to remove it.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental
Discussion, Supplemental Experimental Proce-
dures, and one figure and can be found with this
article online at http://dx.doi.org/10.1016/j.ccr.
2014.06.004.
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